RENNA, SARA
 Distribuzione geografica
Continente #
NA - Nord America 148
EU - Europa 136
AS - Asia 91
SA - Sud America 22
AF - Africa 12
Totale 409
Nazione #
US - Stati Uniti d'America 148
RU - Federazione Russa 69
SG - Singapore 52
IT - Italia 29
BR - Brasile 17
VN - Vietnam 15
CN - Cina 12
IE - Irlanda 10
DE - Germania 6
FR - Francia 5
GB - Regno Unito 5
KR - Corea 4
AR - Argentina 3
CI - Costa d'Avorio 3
NG - Nigeria 3
PL - Polonia 3
SN - Senegal 3
TR - Turchia 3
ES - Italia 2
IL - Israele 2
NL - Olanda 2
AL - Albania 1
BJ - Benin 1
CO - Colombia 1
EC - Ecuador 1
HR - Croazia 1
IQ - Iraq 1
KE - Kenya 1
LB - Libano 1
NO - Norvegia 1
SE - Svezia 1
UA - Ucraina 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 409
Città #
Moscow 37
Singapore 31
Santa Clara 23
Chandler 19
Dallas 15
Ashburn 10
Chicago 10
Dublin 10
Messina 7
San Jose 6
Hanoi 5
San Giuliano Milanese 5
Wilmington 5
Boardman 4
Civitanova Marche 4
Falls Church 4
Ho Chi Minh City 4
Lauterbourg 4
Seoul 4
Abidjan 3
Andover 3
Bremen 3
Buffalo 3
Cambridge 3
Catania 3
Dakar 3
Lawrence 3
Los Angeles 3
Orem 3
Port Harcourt 3
São Paulo 3
Beijing 2
Biên Hòa 2
Civitavecchia 2
Columbus 2
Council Bluffs 2
Dong Ket 2
Frankfurt am Main 2
Manchester 2
Milan 2
The Dalles 2
Warsaw 2
Ambato 1
Amsterdam 1
Araçatuba 1
Atlanta 1
Baghdad 1
Barra Mansa 1
Belo Horizonte 1
Bogotá 1
Brooklyn 1
Buenos Aires 1
Carapicuíba 1
Cinisello Balsamo 1
City of London 1
Cotonou 1
Den Haag 1
Des Moines 1
Gravataí 1
Istanbul 1
Itu 1
Jersey City 1
Johannesburg 1
Juneau 1
Krasnodar 1
Kyiv 1
London 1
Madrid 1
Malacacheta 1
Miami 1
Natal 1
Oslo 1
Pirpirituba 1
Poplar 1
Posadas 1
Quận Ba 1
Recife 1
Sabará 1
Saint Petersburg 1
San Miguel de Tucumán 1
Senhor do Bonfim 1
São José dos Campos 1
Tashkent 1
Tel Aviv 1
Tirana 1
Ufa 1
Várzea Paulista 1
Zagreb 1
Ân Thi 1
Totale 312
Nome #
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients with Crohn's Disease: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease 136
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 123
Letter: SPOSIB SB2—a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2 100
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 58
Totale 417
Categoria #
all - tutte 1.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 5 0 2
2021/202232 5 5 0 1 6 2 4 1 2 0 1 5
2022/202351 3 6 0 9 3 7 0 10 9 0 4 0
2023/202420 1 1 1 1 0 1 7 0 0 0 7 1
2024/202585 0 13 5 6 19 11 4 5 10 4 7 1
2025/2026210 12 1 18 8 50 75 15 6 19 6 0 0
Totale 417